Clinical Study of Novel Skin Biomarker Test for Alzheimer’s Disease Gains Vigorous Physician Support in Long-Sought Early Detection Breakthrough

Author of publication Frederick Huie, MD, Medical DIrector, CVS/Aetna and Advisory Council Member, SYNAPS Dx Scott C. Howell, D.O.
Download
Synaps Dx
DISCERN™ PKCƐ Assay for Alzheimer’s Disease Measuring synaptic dysfunction to inform a highly accurate diagnose Alzheimer’s Dementia in early dementia. Prev post
Morphometric imaging biomarker identifies Alzheimer’s disease even among mixed dementia patients Next post

Recent Posts

Recent Comments

    Archives

    Categories

    Meta